Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology. in Practice|March 21, 2021
A Boxed Warning for Montelukast: The FDA PerspectiveKatherine Clarridge, Stacy Chin, Efe Eworuke, et al.
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?Yoonyoung Choi, Efe Eworuke, Richard Segal
Pharmacoepidemiology and Drug Safety|April 17, 2012
An algorithm to identify preterm infants in administrative claims dataEfe Eworuke, Christian Hampp, Arwa Saidi, et al.
Pediatric Pulmonology|November 10, 2012
Palivizumab immunoprophylaxis effectiveness in children with cystic fibrosisAlmut G Winterstein, Efe Eworuke, Dandan Xu, et al.
Journal of Critical Care|July 18, 2018
National incidence rates for Acute Respiratory Distress Syndrome (ARDS) and ARDS cause-specific factors in the United States (2006-2014)Efe Eworuke, Jacqueline M Major, Lydia I Gilbert McClain
Drug Safety|February 9, 2019
Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine ExposureEfe Eworuke, Emily C Welch, Anne Tobenkin, et al.
Pharmacoepidemiology and Drug Safety|November 16, 2018
Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infantsEfe Eworuke, Genna Panucci, Margie Goulding, et al.
Pharmacoepidemiology and Drug Safety|May 26, 2017
The impact of the boxed warning on the duration of use for depot medroxprogesterone acetateEfe Eworuke, Joo-Yeon Lee, Lisa Soule, et al.
Pageof 6